AI Verdict
IOSP has stronger fundamentals based on our AI analysis.
IOSP vs IONS Fundamental Comparison
| Metric | IOSP | IONS |
|---|---|---|
| Revenue | $1.8B | $203.3M |
| Net Income | $116.6M | $-381.4M |
| Net Margin | 6.6% | -187.6% |
| ROE | 8.8% | -78.0% |
| ROA | 6.4% | -10.8% |
| Current Ratio | 2.79x | 3.83x |
| Debt/Equity | 0.00x | 3.71x |
| EPS | $4.67 | $-2.38 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IOSP vs IONS: Frequently Asked Questions
Is IOSP or IONS a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IOSP has stronger fundamentals. IOSP is rated BUY (72% confidence) while IONS is rated SELL (85% confidence). This is not investment advice.
How does IOSP compare to IONS fundamentally?
INNOSPEC INC. has ROE of 8.8% vs IONIS PHARMACEUTICALS INC's -78.0%. Net margins are 6.6% vs -187.6% respectively.
Which stock pays higher dividends, IOSP or IONS?
IOSP has a dividend yield of N/A or no dividend while IONS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IOSP or IONS for long term?
For long-term investing, consider that IOSP has BUY rating with 72% confidence, while IONS has SELL rating with 85% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IOSP vs IONS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IOSP vs IONS, the AI consensus favors IOSP based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.